Evangelos Bournakis

Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial

Christopher J. Sweeney, Sergio Bracarda, Cora N. Sternberg et al. · The Lancet · 2021 · 313 citations · Full text

Urology, Oncology, Genitourinary Cancer +6

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Florentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou et al. · Breast Cancer Research and Treatment · 2012 · 119 citations

Brca1 Mutations, Breast Oncology, Cancer Epidemiology +10

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy

Aristotle Bamias, Maria Sotiropoulou, Dimitrios Haidopoulos et al. · Cancer · 2010 · 88 citations · Full text

Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer

Martha Zavridou, Αreti Strati, Evangelos Bournakis et al. · Cancers · 2021 · 85 citations · Full text

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

Anna G. Antonacopoulou, Anastasia G Eleftheraki, Foteinos‐Ioannis Dimitrakopoulos et al. · The Pharmacogenomics Journal · 2011 · 75 citations

Medicine, Colorectal Cancer, Pathology +7